Vytrus Biotech, S.A. (FRA:V5P)
8.40
-0.15 (-1.75%)
At close: Jan 30, 2026
Vytrus Biotech Revenue
Vytrus Biotech had revenue of 3.06M EUR in the half year ending December 31, 2024, with 46.56% growth. This brings the company's revenue in the last twelve months to 8.09M, up 54.38% year-over-year. In the year 2024, Vytrus Biotech had annual revenue of 6.09M with 29.51% growth.
Revenue (ttm)
8.09M
Revenue Growth
+54.38%
P/S Ratio
8.56
Revenue / Employee
218.52K
Employees
37
Market Cap
69.22M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.09M | 1.39M | 29.51% |
| Dec 31, 2023 | 4.70M | 219.70K | 4.90% |
| Dec 31, 2022 | 4.48M | 968.83K | 27.57% |
| Dec 31, 2021 | 3.51M | 1.28M | 57.47% |
| Dec 31, 2020 | 2.23M | 456.81K | 25.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WASGAU Produktions & Handels AG | 653.26M |
| Nordwest Handel AG | 273.32M |
| Schwälbchen Molkerei Jakob Berz AG | 209.22M |
| capsensixx AG | 176.29M |
| Meta Wolf AG | 122.26M |
| InnoTec TSS AG | 117.90M |
| audius SE | 90.95M |
| learnd SE | 68.30M |